A genome-wide pleiotropy scan for prostate cancer risk

Kenneth Muir, O A Panagiotou, R C Travis, D Campa, S I Berndt, S Lindstrom, P Kraft, F R Schumacher, A Siddiq, S I Papatheodorou, J L Stanford, D Albanes, J Virtamo, S J Weinstein, W R Diver, S M Gapstur, V L Stevens, H Boeing, H B Bueno-de-Mesquita, A Barricarte GurreaR Kaaks, K T Khaw, V Krogh, K Overvad, E Riboli, D Trichopoulos, E Giovannucci, M Stampfer, C Haiman, B Henderson, L Le Marchand, J M Gaziano, D J Hunter, S Koutros, M Yeager, R N Hoover, S J Chanock, S Wacholder, T J Key, K K Tsilidis

    Research output: Contribution to journalArticlepeer-review


    BACKGROUND: No single-nucleotide polymorphisms (SNPs) specific for aggressive prostate cancer have been identified in genome-wide association studies (GWAS). OBJECTIVE: To test if SNPs associated with other traits may also affect the risk of aggressive prostate cancer. DESIGN, SETTING, AND PARTICIPANTS: SNPs implicated in any phenotype other than prostate cancer (p
    Original languageEnglish
    Pages (from-to)649-57
    Number of pages591
    JournalEur Urol
    Issue number4
    Publication statusPublished - 2015


    Dive into the research topics of 'A genome-wide pleiotropy scan for prostate cancer risk'. Together they form a unique fingerprint.

    Cite this